APCCC 2021 VL

The APCCC 2021 Focuses on Key Areas of Advanced Prostate Cancer Management: Newly Diagnosed mHSPC, PSMA in Diagnostics and Therapy and Novel Targets in mCRPC - Silke Gillessen

Details
Silke Gillessen joins Alicia Morgans highlighting the focus and format of the 2021 Advanced Prostate Cancer Consensus Conference (APCCC) upcoming on the 9th of October starting at 1:00PM CET. This meeting aims to address key areas of prostate cancer practice where there is no clear guidelines or level 1 evidence, The APCCC traditionally holds a biannual international consensus conference where pro...

Looking Forward to The Advanced Prostate Cancer Consensus Conference (APCCC) 2021 - Silke Gillessen and Aurelius Omlin

Details
Silke Gillessen, MD, and Aurelius Omlin, MD join Neal Shore, MD, FACS highlighting the opening of registration for the upcoming Advanced Prostate Cancer Consensus Conference (APCCC) which will be held virtual in October of 2021. Innovations in treatments, imaging, and molecular characterization in advanced prostate cancer have improved outcomes, but there are still many aspects of management that...

Reflections on Advanced Prostate Cancer Consensus Conference 2019 - Srikala Sridhar

Details
Srikala (Kala) Sridhar joins Alicia Morgans to discuss highlights of the advanced prostate cancer consensus conference 2019 sessions. This conference focuses on areas that are controversial and do not have clear evidence to guide the process of prostate cancer care. They cover treatment of the primary in metastatic hormone-sensitive prostate cancer (mHSPC), the importance of understanding the biol...

The Side Effects of Advanced Prostate Cancer Consensus Conference 2019 (APCCC) - Silke Gillessen and Aurelius Omlin

Details
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, mo...
email news signup